Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Suppressing Sart1 to modulate macrophage polarization by siRNA-loaded liposomes: a promising therapeutic strategy for pulmonary fibrosis
Ting Pan, Qing Zhou, Kang Miao, et al.
Theranostics (2020) Vol. 11, Iss. 3, pp. 1192-1206
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Roles of Macrophage Polarization and Macrophage-Derived miRNAs in Pulmonary Fibrosis
Amit Kishore, Martin Petřek
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 166
Adipocyte-derived kynurenine promotes obesity and insulin resistance by activating the AhR/STAT3/IL-6 signaling
Teng Huang, Jia Song, Jia Gao, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 85
Extracellular‐Vesicle‐Based Drug Delivery Systems for Enhanced Antitumor Therapies through Modulating the Cancer‐Immunity Cycle
Tuying Yong, Zhaohan Wei, Lu Gan, et al.
Advanced Materials (2022) Vol. 34, Iss. 52
Closed Access | Times Cited: 82
Recent advances in using liposomes for delivery of nucleic acid-based therapeutics
Hamdi Nsairat, Walhan Alshaer, Fadwa Odeh, et al.
OpenNano (2023) Vol. 11, pp. 100132-100132
Open Access | Times Cited: 60
Dysregulation of metabolic pathways in pulmonary fibrosis
Rishi Rajesh, Reham Atallah, Thomas Bärnthaler
Pharmacology & Therapeutics (2023) Vol. 246, pp. 108436-108436
Open Access | Times Cited: 50
Mitochondrial quality control in human health and disease
Bohao Liu, Chen-Zhen Xu, Yi Liu, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 29
Lactylation‐Driven IGF2BP3‐Mediated Serine Metabolism Reprogramming and RNA m6A—Modification Promotes Lenvatinib Resistance in HCC
Yuanxiang Lu, Jinghan Zhu, Yuxin Zhang, et al.
Advanced Science (2024)
Open Access | Times Cited: 16
Engineering Bioactive M2 Macrophage‐Polarized, Anti‐inflammatory, miRNA‐Based Liposomes for Functional Muscle Repair: From Exosomal Mechanisms to Biomaterials
Zhiwen Luo, Beijie Qi, Yaying Sun, et al.
Small (2022) Vol. 18, Iss. 34
Closed Access | Times Cited: 65
Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients
Chiara Giacomelli, Rebecca Piccarducci, Laura Marchetti, et al.
Biochemical Pharmacology (2021) Vol. 193, pp. 114812-114812
Open Access | Times Cited: 62
Novel drug delivery systems and disease models for pulmonary fibrosis
Rui Li, Yizhen Jia, Xiaohan Kong, et al.
Journal of Controlled Release (2022) Vol. 348, pp. 95-114
Closed Access | Times Cited: 61
Targeted Inhibition of FTO Demethylase Protects Mice Against LPS-Induced Septic Shock by Suppressing NLRP3 Inflammasome
Jia‐Hui Luo, Faxi Wang, Fei Sun, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 59
The methyl-CpG-binding domain 2 facilitates pulmonary fibrosis by orchestrating fibroblast to myofibroblast differentiation
Yi Wang, Lei Zhang, Teng Huang, et al.
European Respiratory Journal (2022) Vol. 60, Iss. 3, pp. 2003697-2003697
Open Access | Times Cited: 51
Tartrate-resistant acid phosphatase 5 promotes pulmonary fibrosis by modulating β-catenin signaling
Yinan Hu, Qi Wang, Jun Yu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 38
si-Tgfbr1-loading liposomes inhibit shoulder capsule fibrosis via mimicking the protective function of exosomes from patients with adhesive capsulitis
Yaying Sun, Zhiwen Luo, Yisheng Chen, et al.
Biomaterials Research (2022) Vol. 26, Iss. 1
Open Access | Times Cited: 38
Emerging delivery approaches for targeted pulmonary fibrosis treatment
Rimpy Diwan, Himanshu Bhatt, Elfa Beaven, et al.
Advanced Drug Delivery Reviews (2023) Vol. 204, pp. 115147-115147
Open Access | Times Cited: 27
Magnetic liposome as a dual-targeting delivery system for idiopathic pulmonary fibrosis treatment
Xi Wang, Yuying Wang, Zhifeng Xue, et al.
Journal of Colloid and Interface Science (2023) Vol. 636, pp. 388-400
Closed Access | Times Cited: 25
TREM2 Insufficiency Protects against Pulmonary Fibrosis by Inhibiting M2 Macrophage Polarization
Qiujie Luo, Dawei Deng, Li Yang, et al.
International Immunopharmacology (2023) Vol. 118, pp. 110070-110070
Open Access | Times Cited: 23
Synergistic Brilliance: Engineered Bacteria and Nanomedicine Unite in Cancer Therapy
Yaofeng Zhou, Qianying Li, Yuhao Wu, et al.
Advanced Materials (2024) Vol. 36, Iss. 21
Closed Access | Times Cited: 15
Macrophage polarization and its impact on idiopathic pulmonary fibrosis
Zhouling Ge, Yong Q. Chen, Leikai Ma, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Nicotinamide phosphoribosyltransferase prompts bleomycin-induced pulmonary fibrosis by driving macrophage M2 polarization in mice
Ya-Ling Chen, Tong Wang, Fuxiang Liang, et al.
Theranostics (2024) Vol. 14, Iss. 7, pp. 2794-2815
Open Access | Times Cited: 8
Inhibition of peptidyl arginine deiminase-4 ameliorated pulmonary fibrosis via modulating M1/M2 polarisation of macrophages
Biswajit Panda, Shrilekha Chilvery, Priyanka Devi, et al.
Life Sciences (2025) Vol. 362, pp. 123354-123354
Closed Access | Times Cited: 1
Local administration of liposomal-based Srpx2 gene therapy reverses pulmonary fibrosis by blockading fibroblast-to-myofibroblast transition
Qi Wang, Juan Liu, Yinan Hu, et al.
Theranostics (2021) Vol. 11, Iss. 14, pp. 7110-7125
Open Access | Times Cited: 49
DNA Origami Frameworks Enabled Self‐Protective siRNA Delivery for Dual Enhancement of Chemo‐Photothermal Combination Therapy
Tingting Xu, Sha Yu, Yao Sun, et al.
Small (2021) Vol. 17, Iss. 46
Closed Access | Times Cited: 41
M2 macrophage polarization in systemic sclerosis fibrosis: pathogenic mechanisms and therapeutic effects
Mingyue Hu, Zhongliu Yao, Lili Xu, et al.
Heliyon (2023) Vol. 9, Iss. 5, pp. e16206-e16206
Open Access | Times Cited: 20
Macrophage-related therapeutic strategies: Regulation of phenotypic switching and construction of drug delivery systems
Xi Wang, Yixuan Li, Xueyu Pu, et al.
Pharmacological Research (2023) Vol. 199, pp. 107022-107022
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top